We believe better drugs start with better translational models! Curious to know more about how we combine complex patient-based cellular disease models with AI-enhanced...
Meet us in Boston!
read more
Patient-based drug discovery's latest news
Meet us in Basel!
This year, Ksilink will be present at several key partnering and business conferences. Curious about our cutting-edge work in disease modeling, AI-driven image analysis for assay...
New publication: The JUMP Cell Painting dataset, studying the morphological impact of 136,000 chemical and genetic perturbations goes public
Since 2019, Ksilink has been part of the JUMP-Cell Painting Consortium, a collaboration between 10 pharmaceutical companies, six supporting technology companies, and two...
